Neowise Biotechnology
Neowise Biotechnology
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors | Solid Metastatic Tumor | Recruiting | Phase 1 | 2025-12-12 | NCT07266298 | |
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor | neoplasm | Recruiting | Phase 1 | 2025-11-25 | NCT06484790 | |
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor | neoplasm | Recruiting | Phase 1 | 2025-11-25 | NCT06478251 | |
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor | neoplasm | Recruiting | Phase 1 | 2025-07-31 | NCT06484556 |